| scholarly article | Q13442814 |
| P2093 | author name string | Adit Ben-Baruch | |
| Galia Luboshits | |||
| Iafa Keydar | |||
| Miguel Weil | |||
| Nely Wigler | |||
| David Shahbazian | |||
| Elina Azenshtein | |||
| Sima Shina | |||
| Eran Neumark | |||
| P433 | issue | 4 | |
| P921 | main subject | breast carcinoma | Q18555947 |
| P304 | page(s) | 1093-1102 | |
| P577 | publication date | 2002-02-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity | |
| P478 | volume | 62 |
| Q38697305 | A Molecular View of Pathological Microcalcification in Breast Cancer |
| Q33316250 | A complex pattern of chemokine receptor expression is seen in osteosarcoma |
| Q40534304 | A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile |
| Q87511744 | Absence of multiple atypical chemokine binders (ACBs) and the presence of VEGF and MMP-9 predict axillary lymph node metastasis in early breast carcinomas |
| Q36950020 | Accumulation of pro-cancer cytokines in the plasma fraction of stored packed red cells. |
| Q41958689 | Adipocytes and Macrophages Interplay in the Orchestration of Tumor Microenvironment: New Implications in Cancer Progression |
| Q60907235 | Aspirin inhibits platelets from reprogramming breast tumor cells and promoting metastasis |
| Q36734935 | C-C chemokine receptor 5 on pulmonary fibrocytes facilitates migration and promotes metastasis via matrix metalloproteinase 9. |
| Q37652169 | CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis |
| Q38193064 | CC chemokine receptor 5: the interface of host immunity and cancer |
| Q64118595 | CC chemokines are differentially expressed in Breast Cancer and are associated with disparity in overall survival |
| Q37729639 | CCL5 as a potential immunotherapeutic target in triple-negative breast cancer |
| Q92753040 | CCL5 mediates target-kinase independent resistance to FLT3 inhibitors in FLT3-ITD-positive AML |
| Q39818502 | CCL5 secreted by senescent aged fibroblasts induces proliferation of prostate epithelial cells and expression of genes that modulate angiogenesis |
| Q47144882 | CCL5-CCR5 interactions modulate metabolic events during tumor onset to promote tumorigenesis |
| Q35845411 | CCL7 and CCL21 overexpression in gastric cancer is associated with lymph node metastasis and poor prognosis |
| Q93183891 | CCR2 Chemokine Receptors Enhance Growth and Cell-Cycle Progression of Breast Cancer Cells through SRC and PKC Activation |
| Q24635191 | CLOCK in breast tumorigenesis: genetic, epigenetic, and transcriptional profiling analyses |
| Q37709158 | Cancer cell CCL5 mediates bone marrow independent angiogenesis in breast cancer. |
| Q41475462 | Carcinoma origin dictates differential skewing of monocyte function |
| Q24684115 | Cathepsin D specifically cleaves the chemokines macrophage inflammatory protein-1 alpha, macrophage inflammatory protein-1 beta, and SLC that are expressed in human breast cancer |
| Q36237839 | Chemokine polymorphisms and lymphoma: a pooled analysis |
| Q64094870 | Chemokines Modulate Immune Surveillance in Tumorigenesis, Metastasis, and Response to Immunotherapy |
| Q93001507 | Chemokines and their Receptors: Multifaceted Roles in Cancer Progression and Potential Value as Cancer Prognostic Markers |
| Q39337489 | Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy |
| Q36918688 | Chemokines: novel targets for breast cancer metastasis |
| Q39951513 | Chemotherapeutic drugs and human tumor cells cytokine network |
| Q38998423 | Cytokine profiling of tumor interstitial fluid of the breast and its relationship with lymphocyte infiltration and clinicopathological characteristics |
| Q36306957 | Data report on inflammatory C-C chemokines among insulin-using women with diabetes mellitus and breast cancer |
| Q41859357 | Differential gene expression during capillary morphogenesis in a microcarrier-based three-dimensional in vitro model of angiogenesis with focus on chemokines and chemokine receptors |
| Q35048124 | Effect of genetic variants in two chemokine decoy receptor genes, DARC and CCBP2, on metastatic potential of breast cancer |
| Q42660944 | Epidermal growth factor and estrogen act by independent pathways to additively promote the release of the angiogenic chemokine CXCL8 by breast tumor cells |
| Q35166851 | Expression of the inflammatory chemokines CCL2, CCL5 and CXCL2 and the receptors CCR1-3 and CXCR2 in T lymphocytes from mammary tumor-bearing mice |
| Q37285629 | Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer. |
| Q30855755 | Genetic polymorphisms of RANTES, IL1-A, MCP-1 and TNF-A genes in patients with prostate cancer |
| Q36813523 | Gold Nanoparticles Doped with (199) Au Atoms and Their Use for Targeted Cancer Imaging by SPECT. |
| Q37809463 | Harnessing the Effect of Adoptively Transferred Tumor‐Reactive T Cells on Endogenous (Host‐Derived) Antitumor Immunity |
| Q35050347 | Heterogeneity of functional properties of Clone 66 murine breast cancer cells expressing various stem cell phenotypes |
| Q24795087 | Host microenvironment in breast cancer development: inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions |
| Q33688703 | Hyperactivated Signaling Pathways of Chemokine RANTES/CCL5 in Osteopathies of Jawbone in Breast Cancer Patients-Case Report and Research |
| Q89818680 | Identification of biomarkers related to CD8+ T cell infiltration with gene co-expression network in clear cell renal cell carcinoma |
| Q34984217 | Inflammatory mediators in breast cancer: coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition |
| Q34977106 | Innate immunity pathways and breast cancer Risk in African American and European-American women in the Women's Circle of Health Study (WCHS). |
| Q37672586 | Insulin secretagogue use and circulating inflammatory C-C chemokine levels in breast cancer patients |
| Q33677002 | Intrapersonal and populational heterogeneity of the chemokine RANTES |
| Q37185068 | LYR71, a derivative of trimeric resveratrol, inhibits tumorigenesis by blocking STAT3-mediated matrix metalloproteinase 9 expression |
| Q37283058 | Lung adenocarcinoma global profiling identifies type II transforming growth factor-beta receptor as a repressor of invasiveness. |
| Q42949508 | Lung adenocarcinoma invasion in TGFbetaRII-deficient cells is mediated by CCL5/RANTES. |
| Q27003907 | Mechanisms driving macrophage diversity and specialization in distinct tumor microenvironments and parallelisms with other tissues |
| Q35763876 | Mechanisms regulating the secretion of the promalignancy chemokine CCL5 by breast tumor cells: CCL5's 40s loop and intracellular glycosaminoglycans |
| Q37014822 | Mesenchymal stem cell-derived CCL-9 and CCL-5 promote mammary tumor cell invasion and the activation of matrix metalloproteinases. |
| Q37697134 | Microenvironmental networks promote tumor heterogeneity and enrich for metastatic cancer stem-like cells in Luminal-A breast tumor cells. |
| Q37100566 | Migratory neighbors and distant invaders: tumor-associated niche cells |
| Q86857534 | Mnk Kinases in Cytokine Signaling and Regulation of Cytokine Responses |
| Q46362794 | Model of vascular desmoplastic multispecies tumor growth |
| Q27480801 | Modulation of RANTES expression by HCV core protein in liver derived cell lines |
| Q36611135 | Modulatory effects of heparin and short-length oligosaccharides of heparin on the metastasis and growth of LMD MDA-MB 231 breast cancer cells in vivo |
| Q64076724 | Molecular Insights Into the Relationship Between Autoimmune Thyroid Diseases and Breast Cancer: A Critical Perspective on Autoimmunity and ER Stress |
| Q38517521 | Multiple effects of TRAIL in human carcinoma cells: induction of apoptosis, senescence, proliferation, and cytokine production |
| Q34810265 | Nf-kappa B, chemokine gene transcription and tumour growth |
| Q33924550 | Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses |
| Q35018318 | Osteopontin promotes CCL5-mesenchymal stromal cell-mediated breast cancer metastasis |
| Q24298015 | Pancreatic adenocarcinoma upregulated factor promotes metastasis by regulating TLR/CXCR4 activation |
| Q37608572 | Platelet-derived growth factor-C (PDGF-C) induces anti-apoptotic effects on macrophages through Akt and Bad phosphorylation |
| Q37402928 | Progression of luminal breast tumors is promoted by ménage à trois between the inflammatory cytokine TNFα and the hormonal and growth-supporting arms of the tumor microenvironment |
| Q35166976 | Quantitative mass spectrometric immunoassay for the chemokine RANTES and its variants |
| Q36797132 | RANTES and fibroblast growth factor 2 in jawbone cavitations: triggers for systemic disease? |
| Q36629504 | RKIP regulates CCL5 expression to inhibit breast cancer invasion and metastasis by controlling macrophage infiltration. |
| Q91774972 | Recent Advances Targeting CCR5 for Cancer and Its Role in Immuno-Oncology |
| Q26784324 | Recent Advances in Discovering the Role of CCL5 in Metastatic Breast Cancer |
| Q36107831 | Reprogramming of Normal Fibroblasts into Cancer-Associated Fibroblasts by miRNAs-Mediated CCL2/VEGFA Signaling |
| Q92793755 | Reverse Cardio-Oncology: Cancer Development in Patients With Cardiovascular Disease |
| Q24805285 | Revisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapy |
| Q49500593 | Role of CCL5/CCR5 in the perineural invasion of salivary adenoid cystic carcinoma cells |
| Q34090617 | Role of Chemokines and Chemokine Receptors in Prostate Cancer Development and Progression |
| Q36120825 | Role of chemokines in tumor growth |
| Q41707680 | Serum chemokine ligand 5 (CCL5/RANTES) level might be utilized as a predictive marker of tumor behavior and disease prognosis in patients with gastric adenocarcinoma |
| Q34096503 | Targeting the intratumoral dendritic cells by the oncolytic adenoviral vaccine expressing RANTES elicits potent antitumor immunity |
| Q28076103 | Targeting tumor-associated macrophages to combat pancreatic cancer |
| Q92154003 | The Composition of Surgical Wound Fluids from Breast Cancer Patients is Affected by Intraoperative Radiotherapy Treatment and Depends on the Molecular Subtype of Breast Cancer |
| Q89847373 | The G protein coupled receptor CCR5 in cancer |
| Q28388630 | The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment |
| Q37970636 | The Tumor-Promoting Flow of Cells Into, Within and Out of the Tumor Site: Regulation by the Inflammatory Axis of TNFα and Chemokines |
| Q38161874 | The immune system and head and neck squamous cell carcinoma: from carcinogenesis to new therapeutic opportunities |
| Q37541911 | The inflammatory chemokine CCL5 and cancer progression |
| Q33587770 | The inflammatory cytokine TNFα cooperates with Ras in elevating metastasis and turns WT-Ras to a tumor-promoting entity in MCF-7 cells |
| Q37269171 | The lupane-type triterpene 30-oxo-calenduladiol is a CCR5 antagonist with anti-HIV-1 and anti-chemotactic activities |
| Q37592479 | The role of CCL5 in the ability of adipose tissue-derived mesenchymal stem cells to support repair of ischemic regions |
| Q36389337 | Therapeutic T cells induce tumor-directed chemotaxis of innate immune cells through tumor-specific secretion of chemokines and stimulation of B16BL6 melanoma to secrete chemokines |
| Q34503208 | Tumor-secreted PGE2 inhibits CCL5 production in activated macrophages through cAMP/PKA signaling pathway |
| Q37948053 | Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the Mesenkillers |
| Q34090273 | Validation of dental X-ray by cytokine RANTES - comparison of X-ray findings with cytokine overexpression in jawbone |
| Q49578198 | WNT5A induces castration-resistant prostate cancer via CCL2 and tumour-infiltrating macrophages |
| Q64884986 | Wound fluids collected postoperatively from patients with breast cancer induce epithelial to mesenchymal transition but intraoperative radiotherapy impairs this effect by activating the radiation-induced bystander effect. |
| Q24633165 | c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion |
Search more.